AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-Receivables" stands at -1.42 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2024, the lowest value since 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.076 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.076 Billion United States Dollars.
The 3 year change is 2.20 Billion United States Dollars.
The 5 year change is 1.79 Billion United States Dollars.
The 10 year change is -1.04 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | Novartis AG - Change Receivables | 255,096,620,580.91 |